Peptely verifies documents. It sells nothing and gives no dosing advice.
GLP-1 peptide · Investigational or research status; verify the current local regulator record

Oxyntomodulin peptide

Oxyntomodulin is a real compound reported in scientific or clinical literature. Its inclusion is not a claim of safety, effectiveness or approval.

Use this Oxyntomodulin peptide record to separate compound identity, human evidence, regulatory status and COA quality. These are related but distinct questions.

Evidence in humansModerate

What is Oxyntomodulin?

Oxyntomodulin is an endogenous gut peptide produced from the proglucagon precursor.

What does it do?

It can signal through both GLP-1 and glucagon receptors and participates in post-meal metabolic and appetite signalling.

Current use and status

Native oxyntomodulin and long-acting analogues are mainly research and development subjects.

Investigational or research status; verify the current local regulator record.

What the evidence does not prove

Short native activity and analogue-specific modifications make findings highly product-specific.

Certificate quality signals

  • Certificate lot and label lot should agree
  • Measured values should name their analytical method
  • The issuing laboratory and report identifier should be independently traceable

Oxyntomodulin peptide reference records

Use the public chemistry and regulatory or clinical-study records to confirm identity and current product status. A database listing is not a product endorsement.

Learn how to assess peptide evidence

Read the peptide safety, sourcing and certificate-verification guides before interpreting a seller or laboratory claim.

Browse peptide guides